Correlation Between IShares Biotechnology and WisdomTree BioRevolution

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Biotechnology and WisdomTree BioRevolution at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Biotechnology and WisdomTree BioRevolution into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Biotechnology ETF and WisdomTree BioRevolution, you can compare the effects of market volatilities on IShares Biotechnology and WisdomTree BioRevolution and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Biotechnology with a short position of WisdomTree BioRevolution. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Biotechnology and WisdomTree BioRevolution.

Diversification Opportunities for IShares Biotechnology and WisdomTree BioRevolution

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between IShares and WisdomTree is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding iShares Biotechnology ETF and WisdomTree BioRevolution in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WisdomTree BioRevolution and IShares Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Biotechnology ETF are associated (or correlated) with WisdomTree BioRevolution. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WisdomTree BioRevolution has no effect on the direction of IShares Biotechnology i.e., IShares Biotechnology and WisdomTree BioRevolution go up and down completely randomly.

Pair Corralation between IShares Biotechnology and WisdomTree BioRevolution

Considering the 90-day investment horizon iShares Biotechnology ETF is expected to generate 0.84 times more return on investment than WisdomTree BioRevolution. However, iShares Biotechnology ETF is 1.2 times less risky than WisdomTree BioRevolution. It trades about -0.01 of its potential returns per unit of risk. WisdomTree BioRevolution is currently generating about -0.11 per unit of risk. If you would invest  13,155  in iShares Biotechnology ETF on December 30, 2024 and sell it today you would lose (126.00) from holding iShares Biotechnology ETF or give up 0.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

iShares Biotechnology ETF  vs.  WisdomTree BioRevolution

 Performance 
       Timeline  
iShares Biotechnology ETF 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days iShares Biotechnology ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, IShares Biotechnology is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
WisdomTree BioRevolution 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days WisdomTree BioRevolution has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Etf's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the ETF investors.

IShares Biotechnology and WisdomTree BioRevolution Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Biotechnology and WisdomTree BioRevolution

The main advantage of trading using opposite IShares Biotechnology and WisdomTree BioRevolution positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Biotechnology position performs unexpectedly, WisdomTree BioRevolution can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WisdomTree BioRevolution will offset losses from the drop in WisdomTree BioRevolution's long position.
The idea behind iShares Biotechnology ETF and WisdomTree BioRevolution pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm